MedicarePartD.guide

A non-government resource built from CMS public data

Mounjaro on SilverScript Choice (S5601-032)

tirzepatide injection

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 4 per 365 days.

$33.93
Patient pays / month, after deductible
$178.57
Patient pays / month, before the $615.00 deductible
$101.78
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MOUNJARO 2.5 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $178.57 for a month. Other covered strengths are listed below.

Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
FormTierPatient pays / monthLimits
MOUNJARO 15 mg/.5mL Injection, Solution3$205.60PA · 2 per 28 days
MOUNJARO 12.5 mg/.5mL Injection, Solution3$205.67PA · 2 per 28 days
MOUNJARO 10 mg/.5mL Injection, Solution3$205.60PA · 2 per 28 days
MOUNJARO 7.5 mg/.5mL Injection, Solution3$205.58PA · 2 per 28 days
MOUNJARO 5 mg/.5mL Injection, Solution3$205.59PA · 2 per 28 days
MOUNJARO 2.5 mg/.5mL Injection, Solution3$33.93PA · 4 per 365 days

Other GLP-1s on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-032